Click HERE for Coronavirus COVID-19 Links for the UCSF Cancer Community

NIH initiative to systematically investigate and establish function of every human gene

UCSFʻs Luke Gilbert, PhD, among recipients of Phase 1 funding of MorPhiC program

Drug Turns Cancer Gene Into “Eat Me” Flag for Immune System

UCSF-Led Study Shows Promising Pre-Clinical Results in Killing Cancer Cells Resistant to Current KRAS-Targeted Treatments

Impact of Climate Change on Cancer Burden

The impact of climate change on human health has come to focus in recent years; however very little is known about the effect of climate change on chronic diseases like cancer. In the latest CureTalks podcast, we discuss climate change, the exposures it generates relevant to cancer, the challenges faced to measure this impact, and the potential disruption to health systems that are essential for cancer control.

microscopic image of pancreatic cancer cells

Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer

A UC San Francisco-led team of international researchers has outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer.

Study Reveals Pregnant Women Are Exposed to Cancer-Causing Chemicals in Dishware, Hair Coloring, Plastics, and Pesticides

Pregnant women in the U.S. are being exposed to chemicals like melamine, cyanuric acid, and aromatic amines that can increase the risk of cancer and harm child development, according to a study from researchers at UC San Francisco and Johns Hopkins Bloomberg School of Public Health.

A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.

Trial Library Emerges Out of Stealth with $5 Million in Seed Funding

Dr. Hala Borno, a University of California, San Francisco (UCSF) oncologist and experienced health equity researcher, introduced a new, tech-enabled approach that prioritizes the need for diverse and underrepresented patient groups.

Microscopic image of tumor tissue from a hepatoblastoma.

New Pediatric Tumor Identifications Could Help Predict Chemo Response

A new UC San Francisco study sheds light on the diversity within the most common type of pediatric liver tumor and suggests a way forward for more precise chemotherapy treatment.

Pre-eminent Scientist, Collaborator, Mentor: Q&A with Nola Hylton, PhD

Dr. Nola Hylton’s path to becoming one of the pre-eminent scientists in the field of biomedical imaging stretches back to childhood when she carried a deep curiosity about the world and “why things are as they are.” In this Q&A, Dr. Hylton talks about choosing a career that would have an impact on others, her enduring excitement for her work, and mentoring women of color in science.

Microscopic image of a group of killer T cells (green and red) surrounding a cancer cell (blue, center). Image by Alex Ritter, Jennifer Lippincott Schwartz and Gillian Griffiths, National Institutes of Health

Giving Immunotherapy Cells Resilience to Pass the “Stress Test”

T cells used in immunotherapy treatments can get exhausted by the task of fighting cancer cells or get shutdown as they enter tumors. Using a CRISPR-based edit on these cells’ genomes, researchers at UC San Francisco and Gladstone Institutes have rendered the therapeutic cells more resilient.

Abortion Ban May Increase Risk of Death for Pregnant Women with Cancer

Katherine Van Loon, MD, and Jordyn Silverstein, MD, from UC San Francisco discuss the unique challenges pregnancy associated cancers (PAC) pose for women and their care teams, who must balance both safety of the mother and that of the fetus or embryo.

Dermatologist Jenna Lester in clinic with a patient examining their scalp.

Training the Eye to See Disease On Dark Skin

Dr. Jenna Lester founded the Skin of Color Program at UC San Francisco, which includes a training clinic that specializes in treating dark skin. There are just a handful of such clinics across the country, and Lester’s is the only one in Northern California.

Understanding the Genesis of Cancer is Goal of $25 Million Award

A world-class team of researchers, co-led by UCSF’s Allan Balmain, and including Kim Rhoads and Luke Gilbert, has been selected to receive a $25M Cancer Grand Challenges award to investigate the very early stages of cancer development.

Portrait Campaign Celebrates Diversity Across Cancer Services

Announcing the Cancer Center See Us Portrait Project, a series of portraits and quotes by Black, Indigenous, People of Color (BIPOC) faculty and staff who are dedicated leaders in diversity, equity, and inclusion, and exhibit UCSF's PRIDE values.